Please login to the form below

Not currently logged in
Email:
Password:

Genzyme’s Henk Doude van Troostwijk joins Raptor Pharmaceutical

US pharma company will also set up European headquarters in the Netherlands

Raptor Pharmaceutical has appointed Henk Doude van Troostwijk as general manager of European commercial operations.

He will be responsible for building and managing Raptor's presence in Europe following the California-based company's decision to establish European headquarters in Leiden, the Netherlands.

Doude van Troostwijk will join the company on April 15 from Sanofi's Genzyme business, where he most recently served as business unit director, oncology, for haematology and transplantation in Northern Europe.

Prior to that he held various roles at Bioenvision, MSD, Bristol-Myers Squibb and Nycomed.

At Raptor his initial focus will be on preparing for the launch and marketing of the company's RP103, an orphan treatment for cell toxicity condition nephropathic cystinosis that is currently being considered for approval by European regulatory authorities.

Patrick Reichenberger, vice president of commercial operations, said: "We are very excited to have Henk join our team to lead the commercial operations in Europe.

“His expertise in gaining market access, working with orphan products and leading commercial teams will be critical as we prepare for the potential launch of RP103 in Europe."

2nd April 2012

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Four Health

Beautiful things happen when you put the right ingredients together. It’s the reason that we mix behaviour change experts with...

Latest intelligence

Is China ready for a pharmaceutical gold rush?
Some describe doing business in China as akin to the 1990s internet boom – so how stable is its future?...
AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...

Infographics